

Off The Scales: The Inside Story of GLP-1s and the Race to Cure Obesity
Off The Scales: The Inside Story of GLP-1s and the Race to Cure ObesityFormat
Audiobook
Listen anywhere
$17.16
Support the people who made thisYour purchase supports the people who made this work
Description
The inside story of the race to develop Ozempic – the world’s first truly effective and safe obesity drug – and its potentially revolutionary effects on public health, and our deeper culture and values.
'A FASCINATING DEEP DIVE' Guardian
'VERY ENGAGING' New Scientist
'ENLIGHTENING' Publishers Weekly
A ‘cure’ for obesity has long evaded the pharmaceutical industry, until the development of Ozempic: a diabetes medication that targets the GLP-1 hormone and makes people feel fuller for longer.
After decades of research, Ozempic’s creator Novo Nordisk
Product details
- Publisher
- HarperCollins UK
- Narrated by
- Yael Rizowy
- Release date
- November 18, 2025
- Length
- 7 h 26 min
- Total file size
- 204 MB
- Audio
- 14 chapters
- Edition
- Unabridged
- Language
- English
- ISBN
- 9780008719111
||
Recommendations